May 7, 2018 Comments (0) Blog, Current Investigations

Relmada Therapeutics (fka Camp Nine, Inc.) – Securities Investigation

Camp Nine

Relmada Therapeutics (Camp Nine) – Investigating Potential Claims

Are you concerned about your investment in Relmada Therapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.

Relmada Therapeutics is a clinical-stage biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases, according to a company announcement.

As of May 20, 2014, Camp Nine, Inc. was acquired by Relmada Therapeutics, Inc., in a reverse merger transaction, according to Bloomberg.

According to SEC filings, Camp Nine filed a Form D to raise capital from investors in 2014 in New York, NY. The total offering amount was $10,694,588 and the total amount sold was $10,694,588.

Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%. According to the Camp Nine Form D, sales commissions for the offering were 10% of the offering amounts.

The problem with private placement investments such as Relmada Therapeutics (Camp Nine) is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.

Is a Private Placement Investment Suitable for you?

The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like Relmada Therapeutics (Camp Nine) to investors.

Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.

If you have concerns regarding your investment in Relmada Therapeutics (Camp Nine) and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.

The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Vero Beach, Florida.

For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttp://www.whitesecuritieslaw.com.